Literature DB >> 33005620

Histopathological and Molecular Features of a Conjunctival Caruncular Deep Penetrating Nevus.

Jolique A van Ipenburg1, Jeffrey Damman1, Dion Paridaens2,3, Robert M Verdijk1,2,4.   

Abstract

We describe the first presentation of a deep penetrating nevus (DPN) on the lacrimal caruncle. This lesion was seen in an 18-year-old woman presenting with hemorrhage of a long-standing pigmented mass on the caruncle. Histology showed a combined melanocytic neoplasm that consisted of two different melanocytic components. The differential diagnosis, based on histological examination, was a conventional melanocytic nevus, a Spitz nevus, or a combined melanocytic nevus. On the molecular level, one of the components revealed a mutation in the CTNNB1 gene encoding the β-catenin protein, while both components harbored a BRAF V600E mutation, without molecular features of a malignant melanocytic lesion. This presentation of a DPN of the lacrimal caruncle emphasizes the similarities of the caruncle with the skin.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  BRAF; Caruncle; Conjunctiva; Deep penetrating nevus; β-Catenin

Year:  2020        PMID: 33005620      PMCID: PMC7506199          DOI: 10.1159/000504966

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  9 in total

1.  Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.

Authors:  Anna E Koopmans; Kimberley Ober; Hendrikus J Dubbink; Dion Paridaens; Nicole C Naus; Stephan Belunek; Bart Krist; Edward Post; Ellen C Zwarthoff; Annelies de Klein; Robert M Verdijk
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 2.  Deep penetrating nevus: a review.

Authors:  Bostjan Luzar; Eduardo Calonje
Journal:  Arch Pathol Lab Med       Date:  2011-03       Impact factor: 5.534

3.  Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.

Authors:  Ryan P Bender; Matthew J McGinniss; Paula Esmay; Elsa F Velazquez; Julie Dr Reimann
Journal:  Mod Pathol       Date:  2013-04-19       Impact factor: 7.842

4.  β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.

Authors:  Arnaud de la Fouchardière; Claire Caillot; Julien Jacquemus; Emeline Durieux; Aurélie Houlier; Véronique Haddad; Daniel Pissaloux
Journal:  Virchows Arch       Date:  2019-02-12       Impact factor: 4.064

5.  Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.

Authors:  Harsha S Reddy; C Dirk Keene; Shu H Chang; Arash Jian-Amadi; Patrick J Cimino
Journal:  Exp Mol Pathol       Date:  2017-02-01       Impact factor: 3.362

6.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 7.  Lesions of the caruncle: a description of 42 cases and a review of the literature.

Authors:  J Levy; M Ilsar; Y Deckel; A Maly; J Pe'er
Journal:  Eye (Lond)       Date:  2008-10-17       Impact factor: 3.775

8.  Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy.

Authors:  Martine J Jager; Robert M Verdijk; Jinfeng Cao; Renier C Heijkants; Aart G Jochemsen; Mehmet Dogrusöz; Mark J de Lange; Pieter A van der Velden; Sjoerd H van der Burg
Journal:  Oncotarget       Date:  2016-07-22

9.  Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi.

Authors:  Iwei Yeh; Ursula E Lang; Emeline Durieux; Meng Kian Tee; Aparna Jorapur; A Hunter Shain; Veronique Haddad; Daniel Pissaloux; Xu Chen; Lorenzo Cerroni; Robert L Judson; Philip E LeBoit; Timothy H McCalmont; Boris C Bastian; Arnaud de la Fouchardière
Journal:  Nat Commun       Date:  2017-09-21       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.